ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia
By H. Jia, D. Look, Lei Shi, M. Hickey, L. Pewe, Jason Netland, M. Farzan, C. Wohlford-Lenane, S. Perlman, P. McCray. Journal of Virology, 2005
841 citations recorded by the source corpus.
Subfields: Infectious Diseases, Obstetrics and Gynecology
View Paper: https://www.semanticscholar.org/paper/16d49cfa9f11cc526939e92c06dbaad780a5205e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Obstetrics and Gynecology
Citations in the corpus
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues (2020, background): “In addition, it has been demonstrated that lung cells highly expressing ACE2 are more readily infected by SARS-CoV [19] .”
- The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status (2020, background): “ACE2, found in the lower respiratory tract of humans, is known as cell receptor for SARS-CoV [27] and regulates both the cross-species and human-to-human transmission [28].”
- Coronavirus Structural Proteins and Virus Assembly (2008, background): “In respiratory epithelial cells, SARS-CoV and human coronavirus strain 229E preferentially enter and are exocytosed from the apical surface (78, 184, 192).”
- Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus (2006, background): “hACE2 is expressed in human airway and alveolar epithelia (13), and SARS-CoV infects primary airway epithelial cells in vitro (14, 34).”
- A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection (2020, background): “The adenoviral AdV-hACE2-GFP construct and defective virus preparation has been reported previously (22).”